Mar 31, 2018

United Therapeutics Q1 2018 Earnings Report

Total Revenue
$389M
Previous year: $371M
+5.0%
EPS
$3.76
Previous year: $3.61
+4.2%
Gross Profit
$336M
Previous year: $356M
-5.7%
Cash and Equivalents
$933M
Previous year: $1.12B
-16.9%
Free Cash Flow
$238M
Previous year: $215M
+10.6%
Total Assets
$3.02B
Previous year: $2.56B
+17.9%

United Therapeutics

United Therapeutics